Development of a novel mechanism-based glycolipid adjuvant for vaccination.

about

Development of a novel mechanism-based glycolipid adjuvant for vaccination.

Item

http://www.wikidata.org/entity/Q55293243

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Development of a novel mechanism-based glycolipid adjuvant for vaccination.

@en

Development of a novel mechanism-based glycolipid adjuvant for vaccination.

@nl

type

Item

label

Development of a novel mechanism-based glycolipid adjuvant for vaccination.

@en

Development of a novel mechanism-based glycolipid adjuvant for vaccination.

@nl

prefLabel

Development of a novel mechanism-based glycolipid adjuvant for vaccination.

@en

Development of a novel mechanism-based glycolipid adjuvant for vaccination.

@nl

P1476

Development of a novel mechanism-based glycolipid adjuvant for vaccination.

@en

P2093

Jordana Grazziela Coelho-Dos-Reis

http://www.w3.org/2001/XMLSchema#string

Xiangming Li

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor

Vaccine Adjuvants: from 1920 to 2015 and Beyond

A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates

CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor

Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells

Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans

Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.

Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.

Activation of NKT cells protects mice from tuberculosis.

Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect.

P31

scholarly article

P356

10.12688/F1000RESEARCH.13794.1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Moriya Tsuji

P577

2018-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29904582

http://www.w3.org/2001/XMLSchema#string

P932

5981189

http://www.w3.org/2001/XMLSchema#string